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Abstract  41 
 42 
The emergence and diffusion of antibiotic-resistant bacteria has been a major public health 43 
problem for many years now. In this study, antibiotic-resistance of coliforms and Escherichia 44 
coli were investigated after their isolation from samples collected in a municipal wastewater 45 
treatment plant in the Milan area (Italy) along different points of the treatment sequence: 46 
inflow to biological treatment; outflow from biological treatment following rapid sand 47 
filtration; and outflow from peracetic acid disinfection. The presence of E. coli that showed 48 
resistance to ampicillin (AMP) and chloramphenicol (CAF), used as representative antibiotics 49 
for the efficacy against Gram-positive and Gram-negative bacteria, was evaluated. After 50 
determining E. coli survival using increasing AMP and CAF concentrations, specific single-51 
resistant (AMPR or CAFR) and double-resistant (AMPR/CAFR) strains were identified among 52 
E. coli colonies, through amplification of the β-lactamase Tem-1 (bla) and acetyl-transferase 53 
catA1 (cat) gene sequences. While a limited number of CAFR bacteria was observed, most 54 
AMPR colonies showed the specific resistance genes to both antibiotics, which was mainly 55 
due to the presence of the bla gene sequence. The peracetic acid, used as disinfection agent, 56 
showed to be very effective in reducing bacteria at the negligible levels of less than 10 57 
CFU/100 ml, compatible with those admitted for the irrigation use of treated waters. 58 
 59 
Keywords: Antibiotic resistance; WWTPs; Escherichia coli; bla and cat genes 60 
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1. Introduction 61 
 62 
Antimicrobial agents are successfully used to treat animal and human diseases. After 63 
discovering bacterial innate resistance, such as the one of Enterobacteria to β-lactams (Sykes 64 
and Matthew, 1976), the extensive and unnecessary use of antibiotics has caused the selection 65 
of antibiotic-resistant bacteria (ARBs) (O'Neill, 2016). Over time, although new antibiotics 66 
were developed to contrast the emergence of ARBs, these have not been able to block the 67 
selection of strains resistant to these new antibiotics (Keen and Montforts, 2012).  68 
 To this purpose, different molecular mechanisms have been described by which 69 
bacteria become antibiotic resistant. The mechanisms include genetic mutations and 70 
horizontal transfer by conjugative plasmids or trasposons of mobile antibiotic resistance genes 71 
(ARG) (Alanis, 2005), easily identified by modern technologies, that may allow the survival 72 
also at high antibiotic concentrations (Meredith et al., 2015). 73 
 Antibiotic resistance has not been completely explored in the environment (Marti et 74 
al., 2014), but the continuous release of antibiotics in wastewater discharges, and their 75 
possible outflow in recycled water for agricultural purposes, may impair autochthonous 76 
bacteria and freshwater ecosystems (Roose-Amsaleg and Laverman, 2015). Sub-inhibitory 77 
antibiotic concentrations were also recently found in environmental settings, as those present 78 
in the aquatic environment (Kümmerer, 2009a; Kümmerer, 2009b), that may promote 79 
antibiotic resistance and select for ARBs (Chow et al., 2015; Gullberg et al., 2011). 80 
Wastewater treatment plants (WWTP) can also be unable to effectively eliminate 81 
water contaminants (Pruden, 2014), which may be dangerous for human health and 82 
ecosystems (Richardson and Ternes, 2014). Many pharmaceuticals can persist in the 83 
environment and they are frequently detected in drinking water. Also, antibiotics are often 84 
administered for economic reasons in the production of food animals to prevent animal 85 
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infectious diseases, thus increasing their possible assumption with the diet by human beings 86 
(Silbergeld et al., 2008). 87 
It is also known that ARG are not easily removed and ARBS may also increase inside 88 
WWTPs, since bacteria are often exposed to antibiotics in activated sludge (Proia et al., 2016; 89 
Rizzo et al., 2013), where microbial concentrations and diversity can also facilitate gene 90 
transfer (Zhang et al., 2009). Bacterial inactivation procedures may also be unable to 91 
deactivate intracellular genes (Dodd, 2012; Sharma et al., 2016), that can persist even after 92 
chlorination (Yuan et al., 2015) although the sequential use of chlorination and UV irradiation 93 
may improve ARG inactivation (Zhang et al., 2015). 94 
WWTPs are therefore sites that need to be monitored, as they may be the recipients of 95 
waters that contain antimicrobials as well as human and animal metabolic waste (Kim and 96 
Aga, 2007) and they can provide a suitable environment for the spread of ARBs (Baquero et 97 
al., 2008; Marathe et al., 2013). Moreover, the fate of antibiotics and other pharmaceuticals 98 
can be strongly influenced not only by WWTP biological/chemical procedures (Sharma et al., 99 
2013), but also by the design and type of treatment system and sewer network as well as by 100 
the efficiency of disinfection (Azzellino et al., 2011; Mezzanotte et al., 2007).  101 
The aim of the present study was to detect ampicillin-resistant (AMPR) and 102 
chloramphenicol-resistant (CAFR) E. coli in the inflow and outflow from a municipal WWTP 103 
in the Milan area (Italy). AMP and CAF were used as representative antibiotics for the 104 
efficacy against Gram-positive and Gram-negative bacteria.  105 
AMP and CAF were chosen as representative of the commonly used antibiotics in 106 
clinic, breedings and research laboratories. Although AMP is more generally used, CAF is 107 
more specific for Enterobacteria such as E. coli, which is the reference standard indicator of 108 
foecal contamination and used to monitor the spread of ARBs in recycled waters (Watkinson 109 
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et al., 2007). Antibiotic resistance was first determined by analysing E. coli survival after 110 
spiking their culture medium with increasing AMP and CAF concentrations.  111 
The extensive use of antibiotics in both human and veterinary medicine can promote 112 
resistance inside WWTPs. The results of this study show that the biological process of this 113 
WWTP is effective in reducing ARB concentration. A prevalence of AMPR versus CAFR E. 114 
coli colonies was also observed, that can be explained by the larger use of β-lactam 115 
antibiotics. After disinfection, ARB removal is almost complete and residual bacteria are 116 
compatible with the irrigation use of treated waters. 117 
 118 
 119 
2. Materials and methods 120 
 121 
2.1. Wastewater treatment plant 122 
The WWTP is located in an urban area of Milan (Italy), and it receives wastewater from the 123 
city (1,250,000 Inhabitant Equivalents, corresponding to 432,000 m3/day average inflow 124 
(Pizza, 2014), which includes that from many hospitals. The within-plant treatment scheme 125 
(Fig. 1) starts with pretreatments (screening, sand and oil removal). This step is followed by 126 
the biological treatment with activated sludge, including pre-denitrification and biological 127 
oxidation (8 h hydraulic retention time, 30 day sludge retention time). After secondary 128 
settling, the biologically treated effluent undergoes rapid sand filtration to improve the 129 
removal of suspended solids and phosphorus.  130 
The final disinfection is based on peracetic acid (about 2 mg/L, 45 min contact time in dry 131 
weather) and aimed at complying with the microbiological limits for the reuse of treated 132 
wastewater for agricultural purposes: 10 E. coli colony forming units (CFU)/100 mL. 133 
 134 
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2.2. Wastewater sampling and physicochemical characterisation 135 
Wastewater samples were collected five times from 19 September to 17 October, 2012, from 136 
three different points in the plant: at the inflow to the biological treatment (i.e., IN-BIO 137 
samples), at the outflow from sand filtration (i.e., OUT-BIO samples), and at the outflow from 138 
disinfection (i.e., OUT-DIS samples) (Fig. 1). All of the samples were collected in sterile dark 139 
bottles, taken to the laboratory in refrigerated bags within 4 h, and immediately processed. 140 
Sodium thiosulphate was added to the WWTP effluent at the concentration required to reach a 141 
neutral pH to quench the residual peracetic acid (United States Environmental Protection 142 
Agency, 2012). The physicochemical characteristics of the samples were determined by 143 
measuring both the total suspended solids (TSS) using the APAT IRSA CNR method (HACH 144 
Lange, Lainate, Milan, Italy) and the chemical oxygen demand (COD) using specific 145 
analytical kits for organic pollutants (HACH) and following the manufacturer’s specifications. 146 
The absorbance for aromatic and unsaturated compounds was determined at 254 nm (OD254) 147 
by the DR 6000 spectrophotometer (HACH). All of these analyses were performed following 148 
the Standard Methods for the Examination of Water and Wastewater of the American Public 149 
Health Association, the American Water Works Association, and the Water Environment 150 
Federation (Rice et al., 2012). 151 
 152 
2.3. Microbiological determination of total coliforms, E. coli, and AMPR or CAFR E. coli 153 
Wastewater samples (100 ml) were filtered through 5-cm-diameter 0.45-µm nitrocellulose 154 
membranes (Sartorius Stedim Biotech, Goettingen, Germany). The membranes were then laid 155 
on plates containing chromogenic agar growth medium (EC X-GLUC agar; Biolife Italiana, 156 
Milan, Italy) to count total coliforms in the presence or absence of antibiotics, and to select 157 
the E. coli green colonies, which are positive for the β-glucoronidase activity. When the 158 
number of bacterial colonies was too high to be counted, the wastewater samples were diluted 159 
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in Ca2+-free and Mg2–-free phosphate buffered saline by 10-2 to 10-4 to have a reliable colony 160 
number. Since green colonies can be mostly ascribed to β-glucoronidase-positive 161 
Enterobacteria, and E. coli is by far the prevalent-one compared to Salmonella and Shigella 162 
(Fekadu et al., 2015), the latter-ones were not taken into consideration. Considering the 163 
EUCAST breakpoint tables, that classify Enterobacteria as AMPR and CAFR when the MIC is 164 
> 8 µg/mL (The European Committee on Antimicrobial Susceptibility Testing (2016; 165 
Choffnes et al., 2011), the E. coli colonies were grown in agar medium where increasing AMP 166 
and CAF concentrations had been added (0, 8, 16, 32 µg/mL; Sigma, St Louis, MO, USA), to 167 
selectively monitor and count the resulting AMPR and CAFR colonies.  168 
The AMP stock solution (50 mg/mL) was prepared in deionised water, filter-sterilised 169 
through 0.45-µm cellulose nitrate membrane, and stored at -20 °C. The CAF stock solution 170 
(50 mg/mL) was prepared in 99% ethanol, and stored at 4 °C.  171 
The plates with the E. coli colonies were incubated for 24 h at 44 °C, and the colony 172 
counts are expressed as CFU/100 mL. The percentage of ARBs was estimated as the ratio 173 
between the number of colonies growing in the presence and absence of the respective 174 
antibiotics. Enumeration of E.coli was carried out five times following the UNI EN ISO 175 
procedure 9308-1:2002 for each combination of three parameters (sampling point, dilution, 176 
and antibiotic concentration), for a total of 120 analyses. 177 
 178 
2.4. Detection of AMPR and CAFR genes and single or double-resistant bla+ and cat+ E. coli 179 
colonies by PCR 180 
From one of the five IN-BIO and five OUT-BIO samples, a maximum of 60 well separated E. 181 
coli green colonies were picked up from the filter membranes, and transferred to the master 182 
plates in the presence of AMP or CAF at 8, 16, 32 µg/mL on Luria Broth (LB)-agar (Biolife 183 
Italiana). The incubations were performed as described above.  184 
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All of the AMPR and CAFR E. coli colonies were grown and screened by PCR to 185 
determine the presence of the β-lactamase Tem-1 (bla) (Baraniak et al., 2005) gene sequence 186 
within the AMPR colonies, and the CAF acetyl-transferase catA1 (cat) gene sequence 187 
(Maynard et al., 2003) within the CAFR colonies, that are the prevalent resistance genes 188 
against these antibiotics. Primers were chosen to detect the bla Tem-1 and catA1 sequences 189 
and amplify 721 bp and 630 bp fragments respectively. For the bla gene, the designed forward 190 
V422 (5’ TTG CTC ACC CAG AAA CGC TG 3’) and reverse V423 (5’ GTC GTG TAG 191 
ATA ACT ACG ATA CG 3’) primers were based on the Tem-1 gene (plasmid pBE135, 192 
accession no. NG_041180). For the cat gene, the designed forward V418 (5’ CAC TGG ATA 193 
TAC CAC CGT TG 3’) and reverse V419 (5’ CAC TCA TCG CAG TAC TGT TG 3’) 194 
primers were based on the catA1 sequence (plasmid pCmGFP accession no. NC_011521). 195 
Amplifications were always carried out in mixtures containing 1 µM of each primer, 200 µM 196 
of each dNTP, and 0.025 U Taq DNA polymerase (Fermentas, Dasit Sciences, Milan, Italy). 197 
This was supplemented with at 2.5 mM MgCl2 for the bla gene, and 1 mM MgCl2 for the cat 198 
gene. For both the bla Tem-1 and catA1 sequences, the PCR conditions were 94 °C for 4 min, 199 
followed by 30 cycles at 94 °C for 30 s, 60 °C for 30 s, and 72 °C for 45 s. The final step was 200 
72 °C for 7 min. The pcDNA3-CAT plasmid, containing both the AMP and CAF resistance 201 
genes, was used as a positive control for the amplification of bla and cat genes, respectively 202 
(Invitrogen Corp., Carlsbad, CA, USA). 203 
To identify the AMPR/CAFR double-resistant E. coli colonies, the AMPR colonies were 204 
also plated in LB-agar spiked with the different AMP or CAF concentrations (i.e., 8/8, 16/16, 205 
32/32 µg/mL). The single- and double-resistant colonies were then screened by PCR for the 206 
presence of the bla and cat gene sequences, and also for both bla and cat. 207 
 208 
2.5. Statistical analyses 209 
 10  
Statistical analyses were performed using one-way ANOVA parametric tests and Bonferroni 210 
analysis of variance, using the Prism 5 software (GraphPad Software Inc., La Jolla, CA, 211 
USA). The significance was set as p <0.05 (*), p <0.01 (**), p <0.001 (***).  212 
 213 
3. Results  214 
 215 
3.1. TSS, COD, and OD254 values decrease in wastewater samples after the biological 216 
treatment and filtration  217 
The analysis of the physical and chemical parameters of the samples showed that, after the 218 
biological treatment and filtration (OUT-BIO versus IN-BIO, Table 1), the TSS, COD, and 219 
OD254 values were reduced from 75 to 3 mg/L (96%), from 162 to 12 mg/L (93%) and from 220 
0.40 to 0.07 OD254 (82.5%), respectively. 221 
 222 
3.2. AMPR E. coli colonies are already selected at 16 µg/mL AMP, and through the 223 
treatments their percentage numbers are only reduced after disinfection  224 
In the absence of antibiotics, the number of E. coli colonies that grew on the chromogenic 225 
agar medium were 3 ×106 CFU/100 mL in IN-BIO samples, and were reduced to 1.5 ×103 226 
CFU/100 mL after the biological treatment in OUT-BIO samples, with a decrease of >3-log 227 
units. A further reduction to <10 CFU/100 mL was found after the final disinfection process, 228 
resulting in >2-log units decrease in OUT-DIS samples.  229 
The relative numbers of AMPR and CAFR E. coli colonies compared to the total E. coli 230 
colonies are shown in Figure 2, as an average of the 10 data obtained per each sampling point 231 
and each AMP (Fig. 2A) and CAF (Fig. 2B) concentration. At any of the AMP concentrations 232 
(Fig. 2A), no significant decrease of ARBs is observed through the biological treatment 233 
(OUT-BIO versus IN-BIO samples), whereas a slight decrease was found for both the IN-BIO 234 
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and OUT-BIO samples with the increase in the antibiotic from 8 µg/mL to 16 µg/mL, with no 235 
further significant changes when using 32 µg/mL. Although a decrease is always present after 236 
disinfection, only at the lowest AMP concentration (8 µg/mL), the treatment with peracetic 237 
acid significantly reduced the AMPR E. coli colonies (3% vs. 37.2%; p <0.05). In the case of 238 
the CAFR E. coli, the colony numbers were always very low, with no significant changes seen 239 
(Fig. 2B). 240 
 241 
3.3. AMPR E. coli colonies increase with AMP concentration as well as bla+ E. coli in OUT-242 
BIO samples 243 
To determine the presence of the bla and cat resistance genes in the E. coli colonies that 244 
survived the exposure to AMP or CAF (i.e., the AMPR and CATR E. coli), the colonies grown 245 
on LB-agar plates were picked up and the specific bla and cat sequences were amplified by 246 
PCR. After electrophoretic separation of the DNA from the selected E. coli colonies, the bla 247 
and cat gene fragments appeared as 721-bp and 630-bp bands, respectively, as shown in the 248 
representative samples in Figure 3. The same fragments for bla and for cat were also 249 
amplified from pcDNA3-CAT plasmid, used as a positive control. 250 
Based on the number of E. coli colonies grown on LB-agar in the presence of the 251 
antibiotics, the AMPR total-coliform colonies showed a decrease of around 2-log units for the 252 
OUT-BIO versus IN-BIO samples at all three of the AMP concentrations; this was paralleled 253 
by the total E. coli colonies (Table 2). Here, after the biological treatment and filtration 254 
process (i.e., the OUT-BIO samples), at 32 µg/mL AMP, the total E. coli colonies represented 255 
60% of the total coliforms, thus indicating that most of the E. coli AMPR colonies were 256 
selected for. Among these total E. coli colonies, in the IN-BIO samples at 8, 16, 32 µg/mL 257 
AMP, the bla gene sequence was present (i.e., the bla+ E. coli) in 97%, 92%, and 78% of the 258 
total AMPR E. coli colonies, respectively, and in the OUT-BIO samples at the same 259 
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concentrations, in 80%, 87% and 91%. Although the CAFR total-coliform colony numbers 260 
showed a similar trend as AMPR total-coliform colonies, in that a decrease of 2-log units was 261 
observed at all CAF concentrations, the cat gene sequence was present (i.e., the cat+ E. coli) at 262 
lower percentages (of CAFR colonies) in IN-BIO samples in 50% and 38% of the total CAFR 263 
E. coli colonies at 16 and 32 µg/mL CAF and in OUT-BIO samples in 67% and 33% at the 264 
same concentrations (Table 2). 265 
 266 
3.4. AMPR/CAFR double-resistant E. coli colonies are mostly bla+, while all cat+ colonies are 267 
bla+/cat+  268 
The AMPR/CAFR double-resistant E. coli colonies were identified by growing AMPR colonies 269 
on the LB medium containing 8, 16, 32 µg/mL CAF. In the IN-BIO samples, the AMPR/CAFR 270 
double-resistant E. coli colonies showed as 33%, 32% and 19%, respectively, and in the OUT-271 
BIO samples they decreased to 17%, 19% and 17% (Table 3). Of these AMPR/CAFR double-272 
resistant colonies, the bla+ colonies were always more represented than the cat+ colonies, and 273 
in both the IN-BIO and OUT-BIO samples at all of the antibiotic concentrations, all of the 274 
cat+ colonies were also bla+/cat+ (Table 3, two last columns). 275 
 276 
4. Discussion  277 
The removal of coliforms and their antibiotic-resistant strains by wastewater treatment 278 
represents an important issue to improve health safety and to reduce the potential horizontal 279 
transfer of genetic resistance factors among bacteria. In this study, the presence of total 280 
coliforms and E. coli AMPR and CAFR strains was investigated in samples from a municipal 281 
WWTP. The single and double-resistance to AMP and CAF were examined in E. coli 282 
colonies and the responsible genes were investigated after amplification of the bla and cat 283 
gene sequences. Although other genes, such as the mecA, bla-AmpC, bla-Oxa-1, bla-SHV-1 284 
 13   
 
and cmlA, flo, have been identified for AMP and CAF resistance, respectively (Giedraitienë et 285 
al., 2011), the bla-TEM-1 (Livermore, 1995) and catA1 (Maynard et al., 2003) sequences were 286 
chosen as the most representative-ones.  287 
These data demonstrate that: (1) the AMPR total E. coli are already selected for at 16 µg/mL 288 
AMP; (2) among AMPR coliforms, AMPR E. coli colonies are well-represented, but not CAFR 289 
E. coli; (3) both AMPR and CAFR total coliforms and E. coli show a 2-log decrease in OUT-290 
BIO samples at all antibiotic concentrations; (4) by increasing AMP concentration, the 291 
percentage of AMPR E. coli colonies increases versus total coliforms and the percentage of 292 
bla+ E. coli increases in OUT-BIO samples; (5) AMPR/CAFR double-resistant E. coli colonies 293 
are mostly bla+ and all of the cat+ colonies are both bla+ and cat+.   294 
The remarkable decrease in TSS, COD and OD254 values supports the efficiency of the 295 
biological treatment and filtration, and the low counts of E.coli in the OUT-DIS samples 296 
confirm the effectiveness of the peracetic acid disinfection. 297 
When the relative numbers of AMPR E. coli colonies were compared to total E. coli at 298 
the different treatment stages, there were no further decreases when the AMP was increased 299 
from 16 µg/mL to 32 µg/mL, thus demonstrating that the selection for AMPR colonies was 300 
already present with 16 µg/mL AMP. Conversely, the low number of CAFR bacteria at all 301 
treatment stages hampered any conclusions for CAF resistance. It is important to note that, 302 
although AMPR bacteria have drastically diminished after the OUT-DIS treatment, no 303 
substantial variation was noticed in the percentage of AMPR colonies by the OUT-BIO 304 
treatment compared to IN-BIO. Since the OUT-BIO treatment reduced by 3 log the number of  305 
E. coli, the persistence of almost the same percentage of AMPR bacteria seems to indicate that 306 
no further selection occurs in spite of the activated sludge treatment. This finding seems to be 307 
in contrast with the increase in antibiotic-resistant bacteria in biological reactors observed in 308 
other studies (Berglund et al., 2015; Marathe et al., 2013; Rizzo et al., 2013; Rodriguez-309 
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Mozaz et al., 2015; Zhang et al., 2009), although at present we have no clear explanation for 310 
this discrepancy. 311 
In AMP-treated samples, the percentage of E. coli colonies versus total coliforms 312 
increased by increasing AMP concentration both in IN-BIO and OUT-BIO samples as well as 313 
the percentage of E. coli carrying the bla resistance gene in OUT-BIO, as if bla was the gene 314 
mostly responsible for resistance. In particular, the relative numbers of bla+ colonies grown at 315 
32 µg/mL increased through the biological treatment and filtration process (i.e., IN-BIO 316 
versus OUT-BIO) from 78% to 91%, as if the retention of bacteria in the biological reactors 317 
favours the selection of AMPR bla+ E. coli. It can be hypothesised that the bla gene sequence 318 
is not only responsible for AMP resistance, but can also make E. coli more resistant to the 319 
biological treatment process. Although CAFR E. coli colonies increase by increasing the 320 
antibiotic concentration,  CAFR E.coli colonies represent a low percentage among CAFR 321 
coliforms. However, E. coli CAF resistance seems to be due to the cat gene, although the 322 
percentage of cat+ E. coli decreases by increasing CAF concentration as if a selection may 323 
occur of bacteria producing higher amounts of enzyme, able to make them resistant to higher 324 
antibiotic concentrations. We can also hypothesize that the increase at 16 µg/mL of cat+ E. 325 
coli in OUT-BIO samples may be due to a selection in favour of cells carrying this resistance 326 
gene.  327 
The decrease in the percentage of AMPR/CAFR double-resistant colonies to around 328 
50% in the OUT-BIO samples only at low CAF concentrations, but not at 32 µg/mL CAF, 329 
seems to indicate that the biological treatment could not be more effective in reducing the 330 
percentage of double-resistant colonies, already selected in the influent (i.e., IN-BIO samples) 331 
at high AMP concentration. As expected, the percentage of AMPR/CAFR double-resistant cat+ 332 
colonies also carried the bla gene sequence, as they were first selected for AMP resistance. 333 
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Overall, the biological process of this WWTP appears to be effective for the reduction 334 
of the numbers of AMPR and CAFR total coliforms and E. coli, by about 2-log units and E. 335 
coli colonies seem to be the most resistant as AMPR E. coli colonies increase compared to 336 
total coliforms with increasing AMP concentration. The high percentage of AMPR E. coli 337 
versus total E. coli in the influent (i.e., the IN-BIO samples) also seems to correlate with the 338 
more than twenty hospitals and clinics in the Milan area from which the plant receives the 339 
wastewaters (Pizza, 2014) 340 
Moreover, although the biological treatment selected for similar levels of AMPR and 341 
CAFR total coliforms, a prevalence of AMPR versus CAFR E. coli colonies was observed. 342 
AMP resistance was related to the presence of the bla gene, the product of which promotes 343 
hydrolysis of the β-lactam ring of AMP, whereas lower levels of cat+ E. coli colonies were 344 
found, which suggests that CAF resistance might be related to mechanisms that do not involve 345 
the cat gene.  The higher levels of AMPR than CAFR E. coli colonies versus total AMPR 346 
coliforms can be explained by the more generalised use of β-lactam antibiotics (e.g., AMP) 347 
versus CAF in the treatment of humans and animals for prevention and control of bacterial 348 
diseases. In Europe, CAF was banned in the veterinary field for the treatment of food-349 
producing animals in 1994 and its use is now limited to pets, whereas it is still indicated in 350 
humans for the therapy of a small number of life-threatening infections (Schwartz et al., 351 
2006). Our data also show that the AMPR and AMPR/CAFR double-resistant E. coli colonies 352 
are related to the presence of the bla gene, which is in agreement with the most frequent 353 
mechanism of AMP resistance in clinically relevant Gram-negative bacteria (Bush and 354 
Jacoby, 2010). 355 
The extensive use of antibiotics in both human and veterinary medicine can promote 356 
resistance inside WWTPs, where bacteria can be exposed to antibiotic doses before being 357 
released into the aquatic environment and the increase of ARBs into the environment may be 358 
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favoured by inefficiently treated domestic and hospital wastewaters (Pruden et al., 2012). As 359 
already shown by other studies (Rodriguez-Mozaz et al., 2015), we have demonstrated that 360 
WWTPs can reduce ARB concentration, but our results seem to indicate that the percentage 361 
of AMPR bacteria remains almost the same after the biological treatment, and thus does not 362 
increase AMPR bacteria although a selection for the bla gene seems to occur. However, after 363 
the disinfection process ARB removal is almost complete and the number of the residual 364 
bacteria is compatible with regulatory guidelines for the irrigation use of treated waters. 365 
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Figure legends 491 
 492 
Figure 1. WWTP scheme and sample collection points.  493 
 494 
Figure 2. AMPR and CAFR E. coli colonies versus total E. coli colonies. The AMPR (A) and 495 
CAFR (B) E. coli colony numbers were determined at the different antibiotic concentrations, 496 
and are expressed as percentages of resistant E. coli colonies compared to total E. coli that 497 
grew on the chromogenic medium in the absence of the antibiotics. AMPR E. coli colonies are 498 
already selected at 16 µg/mL AMP. No significant decrease in the percentage of ARBs is 499 
observed through the biological treatment and filtration (OUT-BIO versus IN-BIO samples), 500 
whereas disinfection significantly reduced the AMPR E. coli colonies (OUT-DIS vs OUT-501 
BIO, p <0.05) at the lowest AMP concentration (8 µg/mL). Bars represent the standard 502 
deviation. 503 
 504 
Figure 3. Representative electrophoresis gels for the PCR-amplified bla and cat gene 505 
sequences of the AMPR and CAFR E. coli colonies. The bla gene fragment appears as a 721-506 
bp DNA band (A) and the cat gene fragment as a 630-bp DNA band (B). (+), positive 507 
colonies; (-), negative colonies; M, molecular weight markers. The pcDNA3-CAT plasmid 508 
was used as the positive controls for bla (C1) and cat (C2), respectively. 509 
 510 
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Table 1.  511 
Main physicochemical characteristics of the wastewater according to the sampling points. 512 
 513 
Sample  Total suspended 
solids (TSS) 
(mg/L) 
Chemical oxygen 
demand (COD) 
(mg/L) 
Optical density  
(OD254)  
 
IN-BIO 75 162 0.40 
OUT-BIO 3 12 0.07 
OUT-DIS 3 <10 0.08 
 514 
 26  
Table 2A.  515 
AMPR total coliform and E. coli colonies grown on LB agar in the presence of AMP. 516 
Antibiotic Sample Total coliforms   E. coli  bla+ E. coli  
  (µg/mL)  (CFU 
/100 mL) 
OUT-BIO 
vs. IN-BIO 
(% reduction) 
 (CFU 
/100 mL) 
vs. total 
coliforms 
(%) 
 (CFU 
/100 mL) 
vs. total 
E. coli 
(%) 
AMP 8 IN-BIO 1.74 ×106 na  6.0 ×105 34  5.8 ×105 97 
 OUT-BIO 2.25 ×104 98.7  6.0 ×103 27  4.8 ×103 80 
AMP 16 IN-BIO 1.10 ×106 na  7.4 ×105 67  6.8 ×105 92 
 OUT-BIO 1.56 ×104 98.6  6.2 ×103 40  5.4 ×103 87 
AMP 32 IN-BIO 0.95 ×106 na  7.3 ×105 77  5.6 ×105 78 
 OUT-BIO 1.19 ×104 98.7  7.1 ×103 60  6.4 ×103 91 
 517 
 518 
Table 2B.  519 
CAFR total coliform and E. coli colonies grown on LB agar in the presence of CAF. 520 
 521 
Antibiotic Sample Total coliforms   E. coli  cat+ E. coli  
  (µg/mL)  (CFU 
/100 mL) 
OUT-BIO 
vs. IN-BIO 
(% reduction) 
 (CFU 
/100 mL) 
vs. total 
coliforms 
(%) 
 (CFU 
/100 mL) 
vs. total 
E. coli 
(%) 
CAF 8 IN-BIO 4.58 ×106 na  5.0 ×105 11  nd nd 
 OUT-BIO 4.80 ×104 98.9  1.0 ×103 2  nd nd 
CAF 16 IN-BIO 3.28 ×106 na  2.0 ×105 6  1.0 ×105 50 
 OUT-BIO 4.72 ×104 98.6  3.0 ×103 6  2.0 ×103 67 
CAF 32 IN-BIO 0.80 ×106 na  2.1 ×105 26  0.8 ×105 38 
 OUT-BIO 1.00 ×104 98.8  1.5 ×103 15  0.5 ×103 33 
 522 
na, not applicable 523 
nd, not determined 524 
 27   
 
Table 3.  525 
AMPR/CAFR double-resistant E. coli colonies first selected on LB agar with AMP and then in 526 
LB agar with CAF at the same antibiotic concentration.  527 
 528 
Antibiotics 
   (µg/mL) 
Sample AMPR/CAFR 
vs. AMPR 
(%) 
bla+ vs. 
AMPR/CAFR 
(%) 
cat+ vs. 
AMPR/CAFR 
(%) 
bla+/cat+ vs. 
AMPR/CAFR 
(%) 
CAF 8 IN-BIO 2.0x105 (33) 2.0x105 (100) 0.4x105 (20) 0.4x105 (20) 
 OUT-BIO 1.0x103 (17) 1.0x103 (100) 0.6x103 (60) 0.6x103 (60) 
CAF 16 IN-BIO 2.4x105 (32) 2.2x105 (92) 0.8x105 (33) 0.8x105 (33) 
 OUT-BIO 1.2x103 (19) 1.0x103 (83) 0.8x103 (66) 0.8x103 (66) 
CAF 32 IN-BIO 1.4x105 (19) 1.2x105 (86) 0.2x105 (29) 0.2x105 (29) 
 OUT-BIO 1.2x103 (17) 1.2x103 (100) 0.8x103 (66) 0.8x103 (66) 
 529 
 530 
 28  
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